75 related articles for article (PubMed ID: 26631551)
1. Neurosteroids: Can a 2alpha,3alpha-epoxy ring make up for the 3alpha-hydroxyl group?
Kasal A; Buděšínský M; Mareš P; Krištofíková Z; Leitão AJ; Sá e Melo ML; Silva MM
Steroids; 2016 Jan; 105():12-8. PubMed ID: 26631551
[TBL] [Abstract][Full Text] [Related]
2. Substituted 3beta-phenylethynyl derivatives of 3alpha-hydroxy-5alpha-pregnan-20-one: remarkably potent neuroactive steroid modulators of gamma-aminobutyric acidA receptors.
Hawkinson JE; Acosta-Burruel M; Yang KC; Hogenkamp DJ; Chen JS; Lan NC; Drewe JA; Whittemore ER; Woodward RM; Carter RB; Upasani RB
J Pharmacol Exp Ther; 1998 Oct; 287(1):198-207. PubMed ID: 9765338
[TBL] [Abstract][Full Text] [Related]
3. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol.
Reddy DS
Neuroscience; 2004; 129(1):195-207. PubMed ID: 15489042
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant potencies of the enantiomers of the neurosteroids androsterone and etiocholanolone exceed those of the natural forms.
Zolkowska D; Dhir A; Krishnan K; Covey DF; Rogawski MA
Psychopharmacology (Berl); 2014 Sep; 231(17):3325-32. PubMed ID: 24705905
[TBL] [Abstract][Full Text] [Related]
6. Partial agonism by 3alpha,21-dihydroxy-5beta-pregnan-20-one at the gamma-aminobutyric acidA receptor neurosteroid site.
Xue BG; Whittemore ER; Park CH; Woodward RM; Lan NC; Gee KW
J Pharmacol Exp Ther; 1997 Jun; 281(3):1095-101. PubMed ID: 9190841
[TBL] [Abstract][Full Text] [Related]
7. Detection of 5α-androst-2-en-17-one and variants: Identification of main urinary metabolites in human urine samples by GC-MS and NMR.
Ayotte C; Sylvestre A; Charlebois A; Poirier D
Drug Test Anal; 2016 Nov; 8(11-12):1174-1185. PubMed ID: 27714952
[TBL] [Abstract][Full Text] [Related]
8. Neurosteroid metabolites of testosterone and progesterone differentially inhibit ERK phosphorylation induced by amyloid β in SH-SY5Y cells and primary cortical neurons.
Mendell AL; Chung BYT; Creighton CE; Kalisch BE; Bailey CDC; MacLusky NJ
Brain Res; 2018 May; 1686():83-93. PubMed ID: 29477545
[TBL] [Abstract][Full Text] [Related]
9. Neurosteroid modulation of recombinant rat alpha5beta2gamma2L and alpha1beta2gamma2L GABA(A) receptors in Xenopus oocyte.
Rahman M; Lindblad C; Johansson IM; Bäckström T; Wang MD
Eur J Pharmacol; 2006 Oct; 547(1-3):37-44. PubMed ID: 16934248
[TBL] [Abstract][Full Text] [Related]
10. Allopregnanolone (3alpha-hydroxy-5alpha-pregnan-20-one) derivatives with a polar chain in position 16alpha: synthesis and activity.
Slavíková B; Kristofíková Z; Chodounská H; Budesínský M; Durán FJ; Veleiro AS; Burton G; Kasal A
J Med Chem; 2009 Apr; 52(7):2119-25. PubMed ID: 19290593
[TBL] [Abstract][Full Text] [Related]
11. Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines.
Barbaccia ML; Carai MA; Colombo G; Lobina C; Purdy RH; Gessa GL
Neuropharmacology; 2005 Jul; 49(1):48-58. PubMed ID: 15992580
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of neurosteroid modulation of native gamma-aminobutyric acid receptors by (3alpha,5alpha)-17-phenylandrost-16-en-3-ol.
Kelley SP; Alan JK; O'Buckley TK; Mennerick S; Krishnan K; Covey DF; Leslie Morrow A
Eur J Pharmacol; 2007 Oct; 572(2-3):94-101. PubMed ID: 17658511
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro biological activity of 4alpha-(2-propenyl)-5alpha-cholest-24-en-3alpha,12 alpha-diol, a 12alpha-hydroxyl analog of 4alpha-(2-propenyl)-5alpha-cholest-24-en-3alpha-ol: the latter is a potent activator of the low-density lipoprotein receptor promoter.
Lin HS; Rampersaud AA; Beavers LS; McClure DB; Gardner AJ; Eacho PI; Foxworthy PS; Gadski RA
Steroids; 1999 Oct; 64(10):735-41. PubMed ID: 10498032
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant activity of androsterone and etiocholanolone.
Kaminski RM; Marini H; Kim WJ; Rogawski MA
Epilepsia; 2005 Jun; 46(6):819-27. PubMed ID: 15946323
[TBL] [Abstract][Full Text] [Related]
15. Neuroactive steroids and GABAA receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy.
Pisu MG; Mostallino MC; Dore R; Mura ML; Maciocco E; Russo E; De Sarro G; Serra M
J Neurochem; 2008 Sep; 106(6):2502-14. PubMed ID: 18624910
[TBL] [Abstract][Full Text] [Related]
16. Ganaxolone, a selective, high-affinity steroid modulator of the gamma-aminobutyric acid-A receptor, exacerbates seizures in animal models of absence.
Snead OC
Ann Neurol; 1998 Oct; 44(4):688-91. PubMed ID: 9778270
[TBL] [Abstract][Full Text] [Related]
17. Differential change in neuroactive steroid sensitivity during ethanol withdrawal.
Finn DA; Gallaher EJ; Crabbe JC
J Pharmacol Exp Ther; 2000 Jan; 292(1):394-405. PubMed ID: 10604976
[TBL] [Abstract][Full Text] [Related]
18. Activity of B-nor analogues of neurosteroids on the GABA(A) receptor in primary neuronal cultures.
Suñol C; García DA; Bujons J; Kristofíková Z; Matyás L; Babot Z; Kasal A
J Med Chem; 2006 Jun; 49(11):3225-34. PubMed ID: 16722640
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptor.
Hogenkamp DJ; Tahir SH; Hawkinson JE; Upasani RB; Alauddin M; Kimbrough CL; Acosta-Burruel M; Whittemore ER; Woodward RM; Lan NC; Gee KW; Bolger MB
J Med Chem; 1997 Jan; 40(1):61-72. PubMed ID: 9016329
[TBL] [Abstract][Full Text] [Related]
20. Genetic differences in behavioral sensitivity to a neuroactive steroid.
Finn DA; Roberts AJ; Lotrich F; Gallaher EJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):820-8. PubMed ID: 9023296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
